Microbiome Responses to Vancomycin Treatment in a Child With Primary Sclerosing Cholangitis and Ulcerative Colitis

The therapeutic effects of off-label oral vancomycin in pediatric and adult primary sclerosing cholangitis (PSC)-inflammatory bowel disease, more commonly PSC-ulcerative colitis (UC), indicate the translational relevance of disease-associated microbiome findings. This is the first report on longitud...

Descripción completa

Detalles Bibliográficos
Autores principales: Britto, Savini Lanka, Hoffman, Kristi Louise, Tessier, Mary Elizabeth, Petrosino, Joseph, Miloh, Tamir, Kellermayer, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116036/
https://www.ncbi.nlm.nih.gov/pubmed/33997090
http://dx.doi.org/10.14309/crj.0000000000000577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116036/
https://www.ncbi.nlm.nih.gov/pubmed/33997090
http://dx.doi.org/10.14309/crj.0000000000000577

Ejemplares similares